402 related articles for article (PubMed ID: 29340540)
21. Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.
Çekiç Ş; Canıtez Y; Sapan N
Turk Pediatri Ars; 2016 Sep; 51(3):152-158. PubMed ID: 27738400
[TBL] [Abstract][Full Text] [Related]
22. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
[TBL] [Abstract][Full Text] [Related]
23. Toxic epidermal necrolysis after phenytoin usage in a brain trauma patient.
Schummer W; Schummer C; Kuwert C
J Neurosurg Anesthesiol; 2002 Jul; 14(3):229-33. PubMed ID: 12172297
[TBL] [Abstract][Full Text] [Related]
24. Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children.
St John J; Ratushny V; Liu KJ; Bach DQ; Badri O; Gracey LE; Ho AW; Raff AB; Sugai DY; Schalock P; Kroshinsky D
Pediatr Dermatol; 2017 Sep; 34(5):540-546. PubMed ID: 28884910
[TBL] [Abstract][Full Text] [Related]
25. Management of toxic epidermal necrolysis.
Craven NM
Hosp Med; 2000 Nov; 61(11):778-81. PubMed ID: 11198746
[TBL] [Abstract][Full Text] [Related]
26. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.
Bastuji-Garin S; Fouchard N; Bertocchi M; Roujeau JC; Revuz J; Wolkenstein P
J Invest Dermatol; 2000 Aug; 115(2):149-53. PubMed ID: 10951229
[TBL] [Abstract][Full Text] [Related]
27. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Prendiville JS; Hebert AA; Greenwald MJ; Esterly NB
J Pediatr; 1989 Dec; 115(6):881-7. PubMed ID: 2585222
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
Lee HY; Fook-Chong S; Koh HY; Thirumoorthy T; Pang SM
J Am Acad Dermatol; 2017 Jan; 76(1):106-113. PubMed ID: 27717620
[TBL] [Abstract][Full Text] [Related]
29. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
McCullough M; Burg M; Lin E; Peng D; Garner W
Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
[TBL] [Abstract][Full Text] [Related]
30. Toxic epidermal necrolysis associated with pembrolizumab.
Cai ZR; Lecours J; Adam JP; Marcil I; Blais N; Dallaire M; Belisle A; Mathieu A
J Oncol Pharm Pract; 2020 Jul; 26(5):1259-1265. PubMed ID: 31810421
[TBL] [Abstract][Full Text] [Related]
31. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JKG; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KMT; Wong GAE; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):e119-e153. PubMed ID: 27287213
[TBL] [Abstract][Full Text] [Related]
32. Treatment of toxic epidermal necrolysis with cyclosporin A.
Arévalo JM; Lorente JA; González-Herrada C; Jiménez-Reyes J
J Trauma; 2000 Mar; 48(3):473-8. PubMed ID: 10744287
[TBL] [Abstract][Full Text] [Related]
33. Burns vs. toxic epidermal necrolysis: A medico-legal dilemma.
Kumar A; Sane MR; Singh A; Harish D
Med Leg J; 2020 Sep; 88(3):160-162. PubMed ID: 32502359
[TBL] [Abstract][Full Text] [Related]
34. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
[TBL] [Abstract][Full Text] [Related]
35. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong.
Ying S; Ho W; Chan HH
Burns; 2001 Jun; 27(4):372-5. PubMed ID: 11348746
[TBL] [Abstract][Full Text] [Related]
36. Experience with toxic epidermal necrolysis treated in a burn center.
Yarbrough DR
J Burn Care Rehabil; 1996; 17(1):30-3. PubMed ID: 8808356
[TBL] [Abstract][Full Text] [Related]
37. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Wilkins J; Morrison L; White CR
Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
[TBL] [Abstract][Full Text] [Related]
38. [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].
Chronopoulos A; Mockenhaupt M; Pleyer U
Ophthalmologe; 2021 May; 118(5):519-532. PubMed ID: 33725172
[TBL] [Abstract][Full Text] [Related]
39. Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins).
Ingen-Housz-Oro S; Duong TA; Bensaid B; Bellon N; de Prost N; Lu D; Lebrun-Vignes B; Gueudry J; Bequignon E; Zaghbib K; Royer G; Colin A; Do-Pham G; Bodemer C; Ortonne N; Barbaud A; Fardet L; Chosidow O; Wolkenstein P;
Orphanet J Rare Dis; 2018 Apr; 13(1):56. PubMed ID: 29636107
[TBL] [Abstract][Full Text] [Related]
40. [Physiopathology and care of toxic epidermal necrolysis].
Roujeau JC
Arch Pediatr; 1999; 6 Suppl 2():296s-298s. PubMed ID: 10370513
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
